During the past decade, Covenant Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 21 clinical trials were completed, i.e. on average, 110.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 13 clinical trials were completed. i.e. 325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covenant Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "University of Nebraska" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Covenant Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (4 trials), "Breast Carcinoma" (3 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Covenant Medical Center" in a lesser frequency.

Most popular intervention types in "Covenant Medical Center" are "Drug" (26 trials), "Other" (22 trials), "Biological" (12 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Placebo" (7 trials), "Quality-of-Life Assessment" (6 trials), "Docetaxel" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Covenant Medical Center" are 31 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Covenant Medical Center". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Covenant Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Covenant Medical Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".